The latest PEG ratio for ERIS.BO is 120.4. That is above the sector sector average of 10.05. Investors often review this figure alongside Eris Lifesciences Limited's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, ERIS.BO currently prints 120.4 for PEG ratio, while the sector average sits near 10.05. That is roughly 1097.4% above the sector mean. Large gaps often invite a closer look at Eris Lifesciences Limited's growth, margins, and balance sheet.

A PEG ratio of 120.4 for Eris Lifesciences Limited is not 'good' or 'bad' on its own. Compare it with the peer average (10.05) and with ERIS.BO's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting ERIS.BO's PEG ratio (120.4), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.